Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01927835
Recruitment Status : Withdrawn
First Posted : August 23, 2013
Last Update Posted : September 23, 2016
HIV Vaccine Trials Network
IPPOX Foundation
EuroVacc Foundation
Global Solutions for Infectious Diseases (GSID)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : January 2017
  Study Completion Date : No date given